Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP59189.RAz0uGCULrs2bpQZQ_t3Ud4Cb2qnvNCwJkZvCdqh1hwNg130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP59189.RAz0uGCULrs2bpQZQ_t3Ud4Cb2qnvNCwJkZvCdqh1hwNg130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP59189.RAz0uGCULrs2bpQZQ_t3Ud4Cb2qnvNCwJkZvCdqh1hwNg130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP59189.RAz0uGCULrs2bpQZQ_t3Ud4Cb2qnvNCwJkZvCdqh1hwNg130_provenance.
- NP59189.RAz0uGCULrs2bpQZQ_t3Ud4Cb2qnvNCwJkZvCdqh1hwNg130_assertion description "[The addition of bevacizumab to paclitaxel does not improve outcomes in relapsed chemosensitive SCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP59189.RAz0uGCULrs2bpQZQ_t3Ud4Cb2qnvNCwJkZvCdqh1hwNg130_provenance.
- NP59189.RAz0uGCULrs2bpQZQ_t3Ud4Cb2qnvNCwJkZvCdqh1hwNg130_assertion evidence source_evidence_literature NP59189.RAz0uGCULrs2bpQZQ_t3Ud4Cb2qnvNCwJkZvCdqh1hwNg130_provenance.
- NP59189.RAz0uGCULrs2bpQZQ_t3Ud4Cb2qnvNCwJkZvCdqh1hwNg130_assertion SIO_000772 21102263 NP59189.RAz0uGCULrs2bpQZQ_t3Ud4Cb2qnvNCwJkZvCdqh1hwNg130_provenance.
- NP59189.RAz0uGCULrs2bpQZQ_t3Ud4Cb2qnvNCwJkZvCdqh1hwNg130_assertion wasDerivedFrom gad-20130706 NP59189.RAz0uGCULrs2bpQZQ_t3Ud4Cb2qnvNCwJkZvCdqh1hwNg130_provenance.
- NP59189.RAz0uGCULrs2bpQZQ_t3Ud4Cb2qnvNCwJkZvCdqh1hwNg130_assertion wasGeneratedBy ECO_0000203 NP59189.RAz0uGCULrs2bpQZQ_t3Ud4Cb2qnvNCwJkZvCdqh1hwNg130_provenance.
- gad-20130706 importedOn "2013-07-06" NP59189.RAz0uGCULrs2bpQZQ_t3Ud4Cb2qnvNCwJkZvCdqh1hwNg130_provenance.